Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
miR-196b-Oct1/2 axis regulates DNMT3A-mutant AML pathogenesis.
Leukemia. 2025 Jan;39(1):229-233. doi: 10.1038/s41375-024-02456-8. Epub 2024 Nov 23.
Leukemia. 2025.
PMID: 39580581
Free PMC article.
No abstract available.
MEN1 mutations mediate clinical resistance to menin inhibition.
Perner F, Stein EM, Wenge DV, Singh S, Kim J, Apazidis A, Rahnamoun H, Anand D, Marinaccio C, Hatton C, Wen Y, Stone RM, Schaller D, Mowla S, Xiao W, Gamlen HA, Stonestrom AJ, Persaud S, Ener E, Cutler JA, Doench JG, McGeehan GM, Volkamer A, Chodera JD, Nowak RP, Fischer ES, Levine RL, Armstrong SA, Cai SF.
Perner F, et al. Among authors: gamlen ha.
Nature. 2023 Mar;615(7954):913-919. doi: 10.1038/s41586-023-05755-9. Epub 2023 Mar 15.
Nature. 2023.
PMID: 36922589
Free PMC article.
Clinical Trial.
Item in Clipboard
miR-196b-TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AML.
Gamlen HA, Romer-Seibert JS, Lawler ME, Versace AM, Goetz ML, Feng Y, Guryanova OA, Palmisiano N, Meyer SE.
Gamlen HA, et al.
Clin Cancer Res. 2022 Oct 14;28(20):4574-4586. doi: 10.1158/1078-0432.CCR-22-1598.
Clin Cancer Res. 2022.
PMID: 35943291
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.